Protalix director gets 17K options, 8.5K RSUs
PLX director Christian Elze received new stock options and RSUs vesting quarterly from a September 3, 2026 grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Protalix BioTherapeutics, Inc. (PLX) reported that director Christian Elze received equity-based awards on September 3, 2026. He was granted 17,000 stock options to buy common stock at an exercise price of $2.59 per share and 8,500 restricted stock units, all held directly. The options and RSUs each vest in 12 equal quarterly installments commencing on the grant date. A separate footnote states he also holds options to purchase 15,000 shares at $1.64 per share expiring September 3, 2035. No Rule 10b5‑1 trading plan is reported for these awards.
Insider Trade Summary
Grant/Award: 25,500 shares
Grant/Award
2 txns
Insider
Elze Christian
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) F1, F2 | 17,000 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units F3, F4 | 8,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Options (Right to Buy) — 17,000 contracts (Direct);
Restricted Stock Units — 8,500 contracts (Direct)
Footnotes (4)
- F1. The shares of common stock underlying the stock options vest in 12 equal quarterly installments commencing upon the date of grant.
- F2. Does not include options to purchase 15,000 shares of common stock at an exercise price equal to $1.64 per share that expire on September 3, 2035.
- F3. Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of the Isuer's common stock.
- F4. The shares of common stock underlying the RSUs vest in 12 equal quarterly installments commencing upon the date of grant.
Key Figures
Stock options granted: 17,000 options
Option exercise price: $2.59 per share
Options expiration date: September 3, 2036
+3 more
6 metrics
Stock options granted
17,000 options
Grant to director Christian Elze on September 3, 2026
Option exercise price
$2.59 per share
Exercise price for 17,000 options granted September 3, 2026
Options expiration date
September 3, 2036
Expiration for 17,000 options granted to Christian Elze
Restricted stock units granted
8,500 RSUs
Grant to director Christian Elze on September 3, 2026
Vesting schedule
12 equal quarterly installments
Applies separately to both the 17,000 options and 8,500 RSUs
Existing options referenced
15,000 options at $1.64 per share
Separate options expiring on September 3, 2035, not part of new grant
Key Terms
Stock Options (Right to Buy), Restricted Stock Units, exercise price, vesting
4 terms
Stock Options (Right to Buy) financial
"security title is listed as Stock Options (Right to Buy)"
Restricted Stock Units financial
"security title is listed as Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
exercise price financial
"options to purchase 15,000 shares of common stock at an exercise price"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares of common stock underlying the RSUs vest in 12 equal quarterly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did PLX director Christian Elze receive on September 3, 2026?
He received 17,000 stock options with an exercise price of $2.59 per share and 8,500 restricted stock units, each RSU representing one share of common stock upon vesting.
How do the new PLX stock options for Christian Elze vest?
The 17,000 stock options vest in 12 equal quarterly installments commencing on the grant date of September 3, 2026, and are exercisable at $2.59 per share until their expiration on September 3, 2036.
How do the new PLX restricted stock units for Christian Elze vest?
The 8,500 restricted stock units vest in 12 equal quarterly installments commencing on the grant date. Each RSU represents the right to receive, following vesting, one share of Protalix BioTherapeutics common stock.
What existing PLX options holdings for Christian Elze are referenced in the filing?
A footnote states that he also holds options to purchase 15,000 shares of common stock at an exercise price of $1.64 per share, which expire on September 3, 2035 and are not included in the newly reported 17,000 options.
Was a Rule 10b5-1 trading plan involved in these PLX transactions?
No. The filing’s Rule 10b5‑1 checkbox is not marked, and there is no footnote indicating these awards were made under a Rule 10b5‑1 trading plan or other pre-arranged trading arrangement.
AI-generated analysis. How Rhea-AI works. Not financial advice.
